Day One Biopharmaceuticals Ownership | Who Owns Day One Biopharmaceuticals?
Day One Biopharmaceuticals Ownership Summary
Day One Biopharmaceuticals is owned by 83.57% institutional investors, 16.87% insiders. Fmr is the largest institutional shareholder, holding 13.34% of DAWN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.43% of its assets in Day One Biopharmaceuticals shares.
DAWN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Day One Biopharmaceuticals | 83.57% | 16.87% | -0.44% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 12.89M | 13.34% | $163.28M |
| Blackrock funding, inc. /de | 9.83M | 9.54% | $63.90M |
| Atlas venture life science advisors | 6.43M | 6.24% | $41.80M |
| Vanguard group | 5.85M | 6.05% | $74.11M |
| Blackrock | 4.53M | 5.23% | $62.47M |
| Franklin resources | 3.88M | 4.02% | $49.20M |
| Deerfield management company, l.p. (series c) | 3.72M | 3.61% | $24.20M |
| Pictet asset management sa | 3.72M | 3.61% | $24.20M |
| State street | 3.10M | 3.21% | $39.30M |
| Alyeska investment group | 3.01M | 2.92% | $19.58M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 6.43M | 6.31% | $41.80M |
| Stonepine capital management | 450.00K | 2.87% | $2.92M |
| Dafna capital management | 879.16K | 1.58% | $5.71M |
| Vestal point capital, lp | 3.00M | 1.03% | $19.50M |
| Boxer capital | 1.19M | 0.86% | $16.40M |
| Braidwell lp | 2.18M | 0.48% | $14.18M |
| Deerfield management company, l.p. (series c) | 3.72M | 0.44% | $24.20M |
| Ecor1 capital | 862.07K | 0.41% | $10.92M |
| Parkman healthcare partners | 500.00K | 0.37% | $3.25M |
| Sphera funds management | 175.37K | 0.27% | $1.14M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 12.89M | 0.01% | 5.48M |
| Blackrock funding, inc. /de | 9.83M | 0.00% | 3.07M |
| Deerfield management company, l.p. (series c) | 3.72M | 0.44% | 762.39K |
| Qube research | 944.20K | 0.01% | 663.42K |
| J. goldman & co lp | 557.48K | 0.09% | 557.48K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -5.76M |
| Estuary capital management lp | - | - | -3.33M |
| Fairmount funds management | - | - | -3.10M |
| Viking global investors lp | - | - | -2.56M |
| Maverick capital | - | - | -2.11M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| J. goldman & co lp | 557.48K | 0.09% | 557.48K | $3.62M |
| Point72 asset management | 391.28K | 0.01% | 391.28K | $2.54M |
| Y-intercept (hong kong) | 281.53K | 0.04% | 281.53K | $1.83M |
| Schroder investment management group | 180.13K | 0.00% | 180.13K | $1.17M |
| Norges bank | 169.00K | 0.00% | 169.00K | $2.14M |
Sold Out
| Holder | Change |
|---|---|
| Pnc financial services group | -3.00 |
| True wealth design | -4.00 |
| Srs capital advisors | -8.00 |
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Northwestern mutual wealth management | -14.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 178 | -6.32% | 86,133,514 | 0.67% | 83 | 1.20% | 101 | -6.48% | 52 | 10.64% |
| Mar 31, 2025 | 193 | 11.56% | 94,051,909 | 0.33% | 91 | 0.97% | 108 | 13.68% | 47 | 20.51% |
| Dec 31, 2024 | 170 | -3.41% | 93,046,512 | 1.26% | 96 | 1.06% | 93 | -8.82% | 40 | 8.11% |
| Sep 30, 2024 | 174 | 6.10% | 91,763,456 | 23.09% | 94 | 1.30% | 102 | 27.50% | 37 | -22.92% |
| Jun 30, 2024 | 163 | 10.14% | 74,549,937 | 2.96% | 86 | 1.04% | 80 | 11.11% | 47 | 9.30% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 2.46M | 2.43% | 522.40K |
| Vanguard Total Stock Mkt Idx Inv | 2.39M | 2.33% | -52.94K |
| Pictet-Biotech P USD | 2.25M | 2.19% | 27.52K |
| Polar Capital Biotech S Inc | 2.11M | 2.06% | - |
| iShares Russell 2000 ETF | 1.66M | 1.62% | -31.61K |
| Franklin Small Cap Growth SMA | 1.61M | 1.59% | 1.61M |
| Franklin US Small Cap Growth Equity | 1.61M | 1.59% | 130.60K |
| Fidelity Small Cap Growth | 1.59M | 1.57% | -4.22K |
| Franklin Biotechnology Discv A(acc)USD | 1.55M | 1.52% | - |
| Franklin Small Cap Growth Adv | 1.48M | 1.45% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 18, 2025 | York Charles N II | COO and CFO | Sell | $27.79K |
| Aug 18, 2025 | Dubow Adam | Gen Counsel & Secretary | Sell | $29.54K |
| Aug 18, 2025 | Bender Jeremy | CHIEF EXECUTIVE OFFICER | Sell | $108.67K |
| Aug 18, 2025 | Merendino Lauren | Chief Commercial Officer | Sell | $25.48K |
| May 16, 2025 | Merendino Lauren | Chief Commercial Officer | Sell | $24.57K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | 4 |
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 9 |
| 2024 Q3 | 1 | 6 |
DAWN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools